SERES THERAPEUTICS INC's ticker is MCRB and the CUSIP is 81750R102. A total of 71 filers reported holding SERES THERAPEUTICS INC in Q4 2015. The put-call ratio across all filers is 0.53 and the average weighting 1.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $460,016 | -44.1% | 193,284 | +12.5% | 0.00% | – |
| Q2 2023 | $822,960 | +164.3% | 171,808 | +212.8% | 0.00% | – |
| Q1 2023 | $311,413 | +4306.6% | 54,923 | +4252.1% | 0.00% | – |
| Q4 2022 | $7,067 | -72.8% | 1,262 | -69.8% | 0.00% | – |
| Q3 2022 | $26,000 | +116.7% | 4,174 | +27.4% | 0.00% | – |
| Q2 2022 | $12,000 | -82.9% | 3,276 | -66.2% | 0.00% | – |
| Q1 2022 | $70,000 | -74.5% | 9,696 | -70.7% | 0.00% | – |
| Q4 2021 | $275,000 | -28.4% | 33,037 | -40.1% | 0.00% | – |
| Q3 2021 | $384,000 | -44.6% | 55,159 | +89.8% | 0.00% | – |
| Q2 2021 | $693,000 | -44.6% | 29,061 | -52.2% | 0.00% | – |
| Q1 2021 | $1,251,000 | -56.9% | 60,738 | -48.8% | 0.00% | -100.0% |
| Q4 2020 | $2,905,000 | -24.3% | 118,568 | -12.5% | 0.00% | 0.0% |
| Q3 2020 | $3,837,000 | +735.9% | 135,578 | +40.8% | 0.00% | – |
| Q2 2020 | $459,000 | +57.2% | 96,278 | +17.6% | 0.00% | – |
| Q1 2020 | $292,000 | +15.9% | 81,836 | +12.1% | 0.00% | – |
| Q4 2019 | $252,000 | -5.3% | 73,025 | +10.1% | 0.00% | – |
| Q3 2019 | $266,000 | +109.4% | 66,333 | +68.1% | 0.00% | – |
| Q2 2019 | $127,000 | -8.6% | 39,466 | +94.3% | 0.00% | – |
| Q1 2019 | $139,000 | +202.2% | 20,313 | +98.9% | 0.00% | – |
| Q4 2018 | $46,000 | -41.8% | 10,211 | -1.9% | 0.00% | – |
| Q3 2018 | $79,000 | -6.0% | 10,410 | +7.7% | 0.00% | – |
| Q2 2018 | $84,000 | -61.6% | 9,666 | -67.6% | 0.00% | – |
| Q1 2018 | $219,000 | -26.0% | 29,821 | +2.2% | 0.00% | – |
| Q4 2017 | $296,000 | +31.0% | 29,183 | +107.2% | 0.00% | – |
| Q3 2017 | $226,000 | +20.2% | 14,086 | -15.6% | 0.00% | – |
| Q2 2017 | $188,000 | -45.3% | 16,684 | -45.3% | 0.00% | – |
| Q1 2017 | $344,000 | -64.3% | 30,518 | -68.6% | 0.00% | – |
| Q4 2016 | $963,000 | +1184.0% | 97,232 | +1485.1% | 0.00% | – |
| Q3 2016 | $75,000 | -59.9% | 6,134 | -4.7% | 0.00% | – |
| Q2 2016 | $187,000 | +45.0% | 6,434 | +32.9% | 0.00% | – |
| Q1 2016 | $129,000 | -15.7% | 4,842 | +10.9% | 0.00% | – |
| Q4 2015 | $153,000 | +15200.0% | 4,366 | +12374.3% | 0.00% | – |
| Q3 2015 | $1,000 | – | 35 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Pioneering Inc. | 21,571,764 | $610,696,000 | 16.87% |
| RA Capital Management | 4,750,000 | $134,473,000 | 2.46% |
| ARK Investment Management | 12,293,033 | $348,016,000 | 2.06% |
| Opaleye Management Inc. | 335,312 | $9,493,000 | 1.86% |
| Sio Capital Management, LLC | 316,800 | $8,969,000 | 1.78% |
| Ikarian Capital, LLC | 762,400 | $21,585,000 | 1.56% |
| Nikko Asset Management Americas, Inc. | 5,531,670 | $152,176,000 | 1.35% |
| EAM Global Investors LLC | 121,629 | $3,443,000 | 1.26% |
| EAM Investors, LLC | 133,591 | $3,782,000 | 0.90% |
| GILDER GAGNON HOWE & CO LLC | 3,185,420 | $90,179,000 | 0.56% |